Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13668
Country/Region: Mozambique
Year: 2018
Main Partner: Ariel Glaser Pediatric AIDS Healthcare Initiative
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $24,300,001 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $2,540,345
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $1,616,583
Care: Pediatric Care and Support (PDCS) $461,881
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $2,771,285
Sexual Prevention: Other Sexual Prevention (HVOP) $200,000
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,005,960
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $13,394,542
Treatment: Pediatric Treatment (PDTX) $2,309,405
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 53
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 14
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 114
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 35
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 40
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 15
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 53
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 15
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 123
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 34
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 271
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 83
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 29
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 9
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 27
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 8
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 230
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 69
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 294
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 84
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 351
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 95
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 391
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 114
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 120
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 30
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 167
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 50
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 113
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 30
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 166
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 49
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 117
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 30
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 166
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 50
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 1,395
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 393
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 1,204
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 337
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 1,732
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 488
GEND_GBV Number of people receiving post-GBV care 2019 2,959
GEND_GBV Number of people receiving post-GBV care 2019 827
HTS_TST <1, Unknown Sex, Negative 2019 18,143
HTS_TST <1, Unknown Sex, Negative 2019 962
HTS_TST 1-9, Unknown Sex, Negative 2019 115,820
HTS_TST 1-9, Unknown Sex, Negative 2019 6,161
HTS_TST 10-14, Female, Negative 2019 22,840
HTS_TST 10-14, Female, Negative 2019 1,212
HTS_TST 10-14, Male, Negative 2019 20,117
HTS_TST 10-14, Male, Negative 2019 1,070
HTS_TST 15-19, Female, Negative 2019 20,459
HTS_TST 15-19, Female, Negative 2019 529
HTS_TST 15-19, Male, Negative 2019 3,988
HTS_TST 15-19, Male, Negative 2019 83
HTS_TST 20-24, Female, Negative 2019 58,826
HTS_TST 20-24, Female, Negative 2019 1,630
HTS_TST 20-24, Male, Negative 2019 15,428
HTS_TST 20-24, Male, Negative 2019 695
HTS_TST 25-29, Female, Negative 2019 200
HTS_TST 25-29, Female, Negative 2019 26
HTS_TST 25-29, Female, Negative 2019 4,796
HTS_TST 25-29, Female, Negative 2019 31
HTS_TST 25-29, Female, Negative 2019 43,438
HTS_TST 25-29, Female, Negative 2019 260
HTS_TST 25-29, Female, Negative 2019 11,449
HTS_TST 25-29, Female, Negative 2019 1,010
HTS_TST 25-29, Female, Negative 2019 3,674
HTS_TST 25-29, Female, Negative 2019 14,168
HTS_TST 25-29, Female, Negative 2019 615
HTS_TST 25-29, Female, Negative 2019 23,239
HTS_TST 25-29, Female, Negative 2019 1,134
HTS_TST 25-29, Male, Negative 2019 193
HTS_TST 25-29, Male, Negative 2019 35
HTS_TST 25-29, Male, Negative 2019 106
HTS_TST 25-29, Male, Negative 2019 30,408
HTS_TST 25-29, Male, Negative 2019 346
HTS_TST 25-29, Male, Negative 2019 8,399
HTS_TST 25-29, Male, Negative 2019 743
HTS_TST 25-29, Male, Negative 2019 4,191
HTS_TST 25-29, Male, Negative 2019 855
HTS_TST 25-29, Male, Negative 2019 17,310
HTS_TST 25-29, Male, Negative 2019 1,199
HTS_TST 30-34, Female, Negative 2019 1,134
HTS_TST 30-34, Female, Negative 2019 200
HTS_TST 30-34, Female, Negative 2019 26
HTS_TST 30-34, Female, Negative 2019 4,796
HTS_TST 30-34, Female, Negative 2019 31
HTS_TST 30-34, Female, Negative 2019 43,438
HTS_TST 30-34, Female, Negative 2019 260
HTS_TST 30-34, Female, Negative 2019 11,449
HTS_TST 30-34, Female, Negative 2019 1,010
HTS_TST 30-34, Female, Negative 2019 3,674
HTS_TST 30-34, Female, Negative 2019 14,168
HTS_TST 30-34, Female, Negative 2019 615
HTS_TST 30-34, Female, Negative 2019 23,239
HTS_TST 30-34, Male, Negative 2019 1,199
HTS_TST 30-34, Male, Negative 2019 193
HTS_TST 30-34, Male, Negative 2019 35
HTS_TST 30-34, Male, Negative 2019 106
HTS_TST 30-34, Male, Negative 2019 30,408
HTS_TST 30-34, Male, Negative 2019 346
HTS_TST 30-34, Male, Negative 2019 8,399
HTS_TST 30-34, Male, Negative 2019 743
HTS_TST 30-34, Male, Negative 2019 4,191
HTS_TST 30-34, Male, Negative 2019 855
HTS_TST 30-34, Male, Negative 2019 17,310
HTS_TST 35-39, Female, Negative 2019 1,134
HTS_TST 35-39, Female, Negative 2019 200
HTS_TST 35-39, Female, Negative 2019 26
HTS_TST 35-39, Female, Negative 2019 4,796
HTS_TST 35-39, Female, Negative 2019 31
HTS_TST 35-39, Female, Negative 2019 43,438
HTS_TST 35-39, Female, Negative 2019 260
HTS_TST 35-39, Female, Negative 2019 11,449
HTS_TST 35-39, Female, Negative 2019 1,010
HTS_TST 35-39, Female, Negative 2019 3,674
HTS_TST 35-39, Female, Negative 2019 14,168
HTS_TST 35-39, Female, Negative 2019 615
HTS_TST 35-39, Female, Negative 2019 23,239
HTS_TST 35-39, Male, Negative 2019 1,199
HTS_TST 35-39, Male, Negative 2019 193
HTS_TST 35-39, Male, Negative 2019 35
HTS_TST 35-39, Male, Negative 2019 106
HTS_TST 35-39, Male, Negative 2019 30,408
HTS_TST 35-39, Male, Negative 2019 346
HTS_TST 35-39, Male, Negative 2019 8,399
HTS_TST 35-39, Male, Negative 2019 743
HTS_TST 35-39, Male, Negative 2019 4,191
HTS_TST 35-39, Male, Negative 2019 855
HTS_TST 35-39, Male, Negative 2019 17,310
HTS_TST 40-49, Female, Negative 2019 1,134
HTS_TST 40-49, Female, Negative 2019 200
HTS_TST 40-49, Female, Negative 2019 26
HTS_TST 40-49, Female, Negative 2019 4,796
HTS_TST 40-49, Female, Negative 2019 31
HTS_TST 40-49, Female, Negative 2019 43,232
HTS_TST 40-49, Female, Negative 2019 260
HTS_TST 40-49, Female, Negative 2019 11,194
HTS_TST 40-49, Female, Negative 2019 1,010
HTS_TST 40-49, Female, Negative 2019 3,674
HTS_TST 40-49, Female, Negative 2019 14,168
HTS_TST 40-49, Female, Negative 2019 615
HTS_TST 40-49, Female, Negative 2019 23,239
HTS_TST 40-49, Male, Negative 2019 1,199
HTS_TST 40-49, Male, Negative 2019 193
HTS_TST 40-49, Male, Negative 2019 35
HTS_TST 40-49, Male, Negative 2019 106
HTS_TST 40-49, Male, Negative 2019 30,161
HTS_TST 40-49, Male, Negative 2019 346
HTS_TST 40-49, Male, Negative 2019 8,399
HTS_TST 40-49, Male, Negative 2019 743
HTS_TST 40-49, Male, Negative 2019 4,191
HTS_TST 40-49, Male, Negative 2019 855
HTS_TST 40-49, Male, Negative 2019 17,310
HTS_TST 50+, Female, Negative 2019 649
HTS_TST 50+, Female, Negative 2019 23,272
HTS_TST 50+, Male, Negative 2019 507
HTS_TST 50+, Male, Negative 2019 16,170
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 71,425
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 1,305,153
HTS_TST Service Delivery Point (Community) Index Mod: <1, Negative 2019 140
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 3,254
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 1,158
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 900
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 2,501
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 1,198
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 2,778
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 1,420
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 2,942
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 2,766
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 19,162
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 7,078
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 34,279
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 11,071
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 10
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 139
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 4,128
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 888
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 26,331
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 174
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 5,204
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 153
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 4,568
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 130
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 5,647
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 18
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 1,004
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 217
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 15,109
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 138
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 3,926
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 158
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 5,606
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 123
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 3,989
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 27
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 1,348
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 241
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 12,025
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 28
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 1,420
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 26
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 1,328
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 12
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 256
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 82
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 52
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 754
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 5
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 384
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 42
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 1,149
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 16
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 779
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 190
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 3,740
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 114
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 77
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 179
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 418
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 33
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 265
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 105
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 632
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 85
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 661
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 861
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 26
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 8,239
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 247
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 2,524
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 75
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 1,887
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 56
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 10,311
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 168
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 2,092
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 83
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 25,987
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 296
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 8,487
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 102
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 12,611
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 112
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 10,804
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 153
HTS_TST_POS <1, Unknown Sex, Positive 2019 192
HTS_TST_POS <1, Unknown Sex, Positive 2019 12
HTS_TST_POS 1-9, Unknown Sex, Positive 2019 1,270
HTS_TST_POS 1-9, Unknown Sex, Positive 2019 82
HTS_TST_POS 10-14, Female, Positive 2019 255
HTS_TST_POS 10-14, Female, Positive 2019 14
HTS_TST_POS 10-14, Male, Positive 2019 223
HTS_TST_POS 10-14, Male, Positive 2019 11
HTS_TST_POS 15-19, Female, Positive 2019 1,214
HTS_TST_POS 15-19, Female, Positive 2019 22
HTS_TST_POS 15-19, Male, Positive 2019 226
HTS_TST_POS 15-19, Male, Positive 2019 3
HTS_TST_POS 20-24, Female, Positive 2019 3,509
HTS_TST_POS 20-24, Female, Positive 2019 68
HTS_TST_POS 20-24, Male, Positive 2019 881
HTS_TST_POS 20-24, Male, Positive 2019 28
HTS_TST_POS 25-29, Female, Positive 2019 3
HTS_TST_POS 25-29, Female, Positive 2019 2
HTS_TST_POS 25-29, Female, Positive 2019 136
HTS_TST_POS 25-29, Female, Positive 2019 2,629
HTS_TST_POS 25-29, Female, Positive 2019 9
HTS_TST_POS 25-29, Female, Positive 2019 809
HTS_TST_POS 25-29, Female, Positive 2019 213
HTS_TST_POS 25-29, Female, Positive 2019 1,428
HTS_TST_POS 25-29, Female, Positive 2019 1,329
HTS_TST_POS 25-29, Female, Positive 2019 36
HTS_TST_POS 25-29, Female, Positive 2019 2,820
HTS_TST_POS 25-29, Female, Positive 2019 47
HTS_TST_POS 25-29, Male, Positive 2019 5
HTS_TST_POS 25-29, Male, Positive 2019 3
HTS_TST_POS 25-29, Male, Positive 2019 3
HTS_TST_POS 25-29, Male, Positive 2019 1,820
HTS_TST_POS 25-29, Male, Positive 2019 14
HTS_TST_POS 25-29, Male, Positive 2019 656
HTS_TST_POS 25-29, Male, Positive 2019 157
HTS_TST_POS 25-29, Male, Positive 2019 1,630
HTS_TST_POS 25-29, Male, Positive 2019 52
HTS_TST_POS 25-29, Male, Positive 2019 2,097
HTS_TST_POS 25-29, Male, Positive 2019 51
HTS_TST_POS 30-34, Female, Positive 2019 47
HTS_TST_POS 30-34, Female, Positive 2019 3
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Female, Positive 2019 136
HTS_TST_POS 30-34, Female, Positive 2019 2,629
HTS_TST_POS 30-34, Female, Positive 2019 9
HTS_TST_POS 30-34, Female, Positive 2019 809
HTS_TST_POS 30-34, Female, Positive 2019 213
HTS_TST_POS 30-34, Female, Positive 2019 1,428
HTS_TST_POS 30-34, Female, Positive 2019 1,329
HTS_TST_POS 30-34, Female, Positive 2019 36
HTS_TST_POS 30-34, Female, Positive 2019 2,820
HTS_TST_POS 30-34, Male, Positive 2019 51
HTS_TST_POS 30-34, Male, Positive 2019 5
HTS_TST_POS 30-34, Male, Positive 2019 3
HTS_TST_POS 30-34, Male, Positive 2019 3
HTS_TST_POS 30-34, Male, Positive 2019 1,820
HTS_TST_POS 30-34, Male, Positive 2019 14
HTS_TST_POS 30-34, Male, Positive 2019 656
HTS_TST_POS 30-34, Male, Positive 2019 157
HTS_TST_POS 30-34, Male, Positive 2019 1,630
HTS_TST_POS 30-34, Male, Positive 2019 52
HTS_TST_POS 30-34, Male, Positive 2019 2,097
HTS_TST_POS 35-39, Female, Positive 2019 47
HTS_TST_POS 35-39, Female, Positive 2019 3
HTS_TST_POS 35-39, Female, Positive 2019 2
HTS_TST_POS 35-39, Female, Positive 2019 136
HTS_TST_POS 35-39, Female, Positive 2019 2,629
HTS_TST_POS 35-39, Female, Positive 2019 9
HTS_TST_POS 35-39, Female, Positive 2019 809
HTS_TST_POS 35-39, Female, Positive 2019 213
HTS_TST_POS 35-39, Female, Positive 2019 1,428
HTS_TST_POS 35-39, Female, Positive 2019 1,329
HTS_TST_POS 35-39, Female, Positive 2019 36
HTS_TST_POS 35-39, Female, Positive 2019 2,820
HTS_TST_POS 35-39, Male, Positive 2019 51
HTS_TST_POS 35-39, Male, Positive 2019 5
HTS_TST_POS 35-39, Male, Positive 2019 3
HTS_TST_POS 35-39, Male, Positive 2019 3
HTS_TST_POS 35-39, Male, Positive 2019 1,820
HTS_TST_POS 35-39, Male, Positive 2019 14
HTS_TST_POS 35-39, Male, Positive 2019 656
HTS_TST_POS 35-39, Male, Positive 2019 157
HTS_TST_POS 35-39, Male, Positive 2019 1,630
HTS_TST_POS 35-39, Male, Positive 2019 52
HTS_TST_POS 35-39, Male, Positive 2019 2,097
HTS_TST_POS 40-49, Female, Positive 2019 47
HTS_TST_POS 40-49, Female, Positive 2019 3
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Female, Positive 2019 136
HTS_TST_POS 40-49, Female, Positive 2019 2,629
HTS_TST_POS 40-49, Female, Positive 2019 9
HTS_TST_POS 40-49, Female, Positive 2019 796
HTS_TST_POS 40-49, Female, Positive 2019 213
HTS_TST_POS 40-49, Female, Positive 2019 1,428
HTS_TST_POS 40-49, Female, Positive 2019 1,329
HTS_TST_POS 40-49, Female, Positive 2019 36
HTS_TST_POS 40-49, Female, Positive 2019 2,820
HTS_TST_POS 40-49, Male, Positive 2019 51
HTS_TST_POS 40-49, Male, Positive 2019 5
HTS_TST_POS 40-49, Male, Positive 2019 3
HTS_TST_POS 40-49, Male, Positive 2019 3
HTS_TST_POS 40-49, Male, Positive 2019 1,816
HTS_TST_POS 40-49, Male, Positive 2019 14
HTS_TST_POS 40-49, Male, Positive 2019 656
HTS_TST_POS 40-49, Male, Positive 2019 157
HTS_TST_POS 40-49, Male, Positive 2019 1,630
HTS_TST_POS 40-49, Male, Positive 2019 52
HTS_TST_POS 40-49, Male, Positive 2019 2,097
HTS_TST_POS 50+, Female, Positive 2019 25
HTS_TST_POS 50+, Female, Positive 2019 1,368
HTS_TST_POS 50+, Male, Positive 2019 21
HTS_TST_POS 50+, Male, Positive 2019 950
HTS_TST_POS Service Delivery Point (Community) Index Mod: <1, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 50
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 17
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 13
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 973
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 467
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 1,081
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 553
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 1,144
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 1,076
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 1,632
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 176
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 3,179
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 302
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 289
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 51
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 435
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 56
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 1,008
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 239
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 358
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 276
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 129
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 139
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 75
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 225
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 152
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 213
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 28
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 43
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 193
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 52
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 1,216
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 231
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 3,139
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 990
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 1,472
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 1,259
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 8
PMTCT_ART Already on ART at beginning of current pregnancy 2019 8,287
PMTCT_ART Already on ART at beginning of current pregnancy 2019 679
PMTCT_ART New on ART 2019 9,241
PMTCT_ART New on ART 2019 932
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 17,528
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 1,611
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 132,992
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 39,025
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 14,019
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 1,296
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 3,513
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 318
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 17,532
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 1,614
PMTCT_EID Sum of Infant Age disaggregates 2019 17,532
PMTCT_EID Sum of Infant Age disaggregates 2019 1,614
PMTCT_STAT 25-29, Female 2019 58,480
PMTCT_STAT 25-29, Female 2019 8,843
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 1,021
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 231
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 55,295
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 7,961
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 2,004
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 646
PMTCT_STAT 30-34, Female 2019 1,492
PMTCT_STAT 30-34, Female 2019 3,062
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 820
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 230
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 2,627
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 644
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 193
PMTCT_STAT 35-39, Female 2019 1,012
PMTCT_STAT 35-39, Female 2019 2,857
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 806
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 228
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 2,568
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 645
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 194
PMTCT_STAT 40-49, Female 2019 1,004
PMTCT_STAT 40-49, Female 2019 2,827
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 801
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 228
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 2,540
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 643
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 193
PMTCT_STAT By Age (Numerator): : 15-19 2019 7,943
PMTCT_STAT By Age (Numerator): <10 2019 2
PMTCT_STAT By Age (Numerator): 10-14 2019 2,181
PMTCT_STAT By Age (Numerator): 10-14 2019 616
PMTCT_STAT By Age (Numerator): 15-19 2019 33,404
PMTCT_STAT By Age (Numerator): 20-24 2019 35,178
PMTCT_STAT By Age (Numerator): 20-24 2019 9,315
PMTCT_STAT By Age (Numerator): 50+ 2019 83
PMTCT_STAT By Age (Numerator): 50+ 2019 1
PMTCT_STAT By known positives: 10-14 2019 21
PMTCT_STAT By known positives: 15-19 2019 76
PMTCT_STAT By known positives: 20-24 2019 262
PMTCT_STAT By new negatives: 10-14 2019 519
PMTCT_STAT By new negatives: 15-19 2019 7,550
PMTCT_STAT By new negatives: 20-24 2019 8,560
PMTCT_STAT By new negatives: 50+ 2019 1
PMTCT_STAT By new positives: 15-19 2019 192
PMTCT_STAT By new positives: 20-24 2019 442
PMTCT_STAT By Number of known positives: 10-14 2019 1
PMTCT_STAT By Number of known positives: 15-19 2019 317
PMTCT_STAT By Number of known positives: 20-24 2019 863
PMTCT_STAT By Number of known positives: 50+ 2019 31
PMTCT_STAT By Number of new negative: <10 2019 2
PMTCT_STAT By Number of new negative: 10-14 2019 2,021
PMTCT_STAT By Number of new negative: 15-19 2019 31,982
PMTCT_STAT By Number of new negative: 20-24 2019 32,655
PMTCT_STAT By Number of new negative: 50+ 2019 50
PMTCT_STAT By Number of new positives: 10-14 2019 105
PMTCT_STAT By Number of new positives: 15-19 2019 639
PMTCT_STAT By Number of new positives: 20-24 2019 1,502
PMTCT_STAT By Number of new positives: 50+ 2019 1
PMTCT_STAT Number of new ANC and L&D clients 2019 136,135
PMTCT_STAT Number of new ANC and L&D clients 2019 39,988
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 132,992
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 39,025
PMTCT_STAT_den 25-29, Female 2019 25,683
PMTCT_STAT_den 25-29, Female 2019 6,540
PMTCT_STAT_den 30-34, Female 2019 18,892
PMTCT_STAT_den 30-34, Female 2019 6,106
PMTCT_STAT_den 35-39, Female 2019 17,675
PMTCT_STAT_den 35-39, Female 2019 6,281
PMTCT_STAT_den 40-49, Female 2019 17,810
PMTCT_STAT_den 40-49, Female 2019 6,274
PMTCT_STAT_den By Age (Denominator): <15-19 2019 25,189
PMTCT_STAT_den By Age (Denominator): 10-14 2019 1,014
PMTCT_STAT_den By Age (Denominator): 10-14 2019 594
PMTCT_STAT_den By Age (Denominator): 15-19 2019 6,539
PMTCT_STAT_den By Age (Denominator): 20-24 2019 29,802
PMTCT_STAT_den By Age (Denominator): 20-24 2019 7,652
PMTCT_STAT_den By Age (Denominator): 50+ 2019 70
PMTCT_STAT_den By Age (Denominator): 50+ 2019 2
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 90
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 2
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 1,388
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 75
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 134
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 1,598
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 105
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 3,438
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 191
TB_PREV By Age/Sex (Numerator): <15, Female 2019 1,698
TB_PREV By Age/Sex (Numerator): <15, Female 2019 37
TB_PREV By Age/Sex (Numerator): <15, Male 2019 1,467
TB_PREV By Age/Sex (Numerator): <15, Male 2019 18
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 40,647
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 707
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 22,424
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 392
TB_PREV IPT, Life-long ART, Already, Positive 2019 13,239
TB_PREV IPT, Life-long ART, Already, Positive 2019 233
TB_PREV IPT, Life-long ART, New, Positive 2019 52,986
TB_PREV IPT, Life-long ART, New, Positive 2019 921
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 66,225
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 1,154
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 88,278
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 1,531
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 2,283
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 38
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 2,073
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 33
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 53,211
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 923
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 30,720
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 532
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 17,651
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 306
TB_PREV_den IPT, Life-long ART, New, Positive 2019 70,596
TB_PREV_den IPT, Life-long ART, New, Positive 2019 1,222
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 438
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 36
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 4,627
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 454
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 575
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 65
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 5,824
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 586
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 11,496
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 1,147
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 11,496
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 1,147
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 497
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 38
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 4,424
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 445
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 574
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 63
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 5,992
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 599
TX_CURR 25-29, Female, Positive 2019 34,068
TX_CURR 25-29, Female, Positive 2019 1,094
TX_CURR 25-29, Male, Positive 2019 14,040
TX_CURR 25-29, Male, Positive 2019 510
TX_CURR 30-34, Female, Positive 2019 34,026
TX_CURR 30-34, Female, Positive 2019 1,094
TX_CURR 30-34, Male, Positive 2019 14,051
TX_CURR 30-34, Male, Positive 2019 511
TX_CURR 35-39, Female, Positive 2019 34,050
TX_CURR 35-39, Female, Positive 2019 1,090
TX_CURR 35-39, Male, Positive 2019 14,037
TX_CURR 35-39, Male, Positive 2019 516
TX_CURR 40-49, Female, Positive 2019 34,036
TX_CURR 40-49, Female, Positive 2019 1,094
TX_CURR 40-49, Male, Positive 2019 14,042
TX_CURR 40-49, Male, Positive 2019 512
TX_CURR Age/Sex: <1 2019 705
TX_CURR Age/Sex: <1 2019 105
TX_CURR Age/Sex: <1-9 2019 13,073
TX_CURR Age/Sex: 1-9 2019 731
TX_CURR Age/Sex: 10-14 Female 2019 2,884
TX_CURR Age/Sex: 10-14 Female 2019 80
TX_CURR Age/Sex: 10-14 Male 2019 2,643
TX_CURR Age/Sex: 10-14 Male 2019 49
TX_CURR Age/Sex: 15-19 Female 2019 7,073
TX_CURR Age/Sex: 15-19 Female 2019 344
TX_CURR Age/Sex: 15-19 Male 2019 1,409
TX_CURR Age/Sex: 15-19 Male 2019 29
TX_CURR Age/Sex: 20-24 Female 2019 21,270
TX_CURR Age/Sex: 20-24 Female 2019 1,045
TX_CURR Age/Sex: 20-24 Male 2019 2,699
TX_CURR Age/Sex: 20-24 Male 2019 158
TX_CURR Age/Sex: 50+ Female 2019 24,384
TX_CURR Age/Sex: 50+ Female 2019 528
TX_CURR Age/Sex: 50+ Male 2019 15,860
TX_CURR Age/Sex: 50+ Male 2019 436
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 284,561
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 9,984
TX_CURR Sum of age/sex disaggregates 2019 8,482
TX_CURR Sum of Age/Sex disaggregations 2019 373
TX_NEW 25-29, Female, Positive 2019 10,824
TX_NEW 25-29, Female, Positive 2019 149
TX_NEW 25-29, Male, Positive 2019 6,435
TX_NEW 25-29, Male, Positive 2019 110
TX_NEW 30-34, Female, Positive 2019 10,823
TX_NEW 30-34, Female, Positive 2019 150
TX_NEW 30-34, Male, Positive 2019 6,438
TX_NEW 30-34, Male, Positive 2019 111
TX_NEW 35-39, Female, Positive 2019 10,822
TX_NEW 35-39, Female, Positive 2019 150
TX_NEW 35-39, Male, Positive 2019 6,437
TX_NEW 35-39, Male, Positive 2019 109
TX_NEW 40-49, Female, Positive 2019 10,821
TX_NEW 40-49, Female, Positive 2019 146
TX_NEW 40-49, Male, Positive 2019 6,436
TX_NEW 40-49, Male, Positive 2019 104
TX_NEW Breastfeeding status 2019 2,131
TX_NEW Breastfeeding status 2019 34
TX_NEW By Age/Sex: <1 2019 684
TX_NEW By Age/Sex: <1 2019 30
TX_NEW By Age/Sex: 1-9 2019 2,095
TX_NEW By Age/Sex: 1-9 2019 121
TX_NEW By Age/Sex: 10-14 Female 2019 361
TX_NEW By Age/Sex: 10-14 Female 2019 22
TX_NEW By Age/Sex: 10-14 Male 2019 291
TX_NEW By Age/Sex: 10-14 Male 2019 12
TX_NEW By Age/Sex: 15-19 Female 2019 4,991
TX_NEW By Age/Sex: 15-19 Female 2019 83
TX_NEW By Age/Sex: 15-19 Male 2019 570
TX_NEW By Age/Sex: 15-19 Male 2019 1
TX_NEW By Age/Sex: 20-24 Female 2019 12,787
TX_NEW By Age/Sex: 20-24 Female 2019 224
TX_NEW By Age/Sex: 20-24 Male 2019 2,186
TX_NEW By Age/Sex: 20-24 Male 2019 48
TX_NEW By Age/Sex: 50+ Female 2019 6,395
TX_NEW By Age/Sex: 50+ Female 2019 63
TX_NEW By Age/Sex: 50+ Male 2019 4,604
TX_NEW By Age/Sex: 50+ Male 2019 56
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 103,920
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 1,710
TX_NEW Pregnancy status 2019 15,982
TX_NEW Pregnancy status 2019 312
TX_NEW Sum of Age/Sex disaggregates 2019 32,185
TX_NEW Sum of Age/Sex disaggregates 2019 509
TX_PVLS <15, Undocumented Test Indication, Female 2019 300
TX_PVLS <15, Undocumented Test Indication, Female 2019 7,773
TX_PVLS <15, Undocumented Test Indication, Male 2019 127
TX_PVLS <15, Undocumented Test Indication, Male 2019 3,037
TX_PVLS 15+, Undocumented Test Indication, Female 2019 4,467
TX_PVLS 15+, Undocumented Test Indication, Female 2019 119,195
TX_PVLS 15+, Undocumented Test Indication, Male 2019 1,859
TX_PVLS 15+, Undocumented Test Indication, Male 2019 45,787
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 175,792
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 6,753
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 863
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 22
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 378
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 9
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 39,243
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,103
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 15,941
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 482
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 56,561
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 1,636
TX_RET Numerator by Status: Breastfeeding 2019 4,115
TX_RET Numerator by Status: Breastfeeding 2019 120
TX_RET Numerator by Status: Pregnant 2019 8,763
TX_RET Numerator by Status: Pregnant 2019 221
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 62,912
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 1,813
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 955
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 22
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 452
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 8
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 42,945
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,196
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 18,435
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 568
TX_RET_den Denominator by Status: Breastfeeding 2019 4,140
TX_RET_den Denominator by Status: Breastfeeding 2019 111
TX_RET_den Denominator by Status: Pregnant 2019 9,482
TX_RET_den Denominator by Status: Pregnant 2019 282
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 284,561
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 9,988
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 11,153
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 396
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 10,136
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 368
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2019 6,458
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2019 2,675
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 189,279
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 72,505
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 2,811
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 105
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 63
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 121
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 226
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 2,874
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 193,431
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 6,775
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 22,686
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 783
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 62,529
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 2,179
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 5,622
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 183
Cross Cutting Budget Categories and Known Amounts Total: $7,811,607
Key Populations: MSM and TG $150,000
Training of health workers and community outreach workers
Key Populations: Sex Workers $150,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Gender: Gender Based Violence (GBV) $280,400
GBV Prevention
Motor Vehicles: Purchased $100,000
Human Resources for Health $6,083,356
Condoms: Policy, Tools, and Services $200,000
Food and Nutrition: Policy, Tools, and Service Delivery $220,000
Renovation $427,851
Adolescent Girls and Young Women (AGYW) $200,000